352
Participants
Start Date
August 31, 2014
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
Botulinum purified neurotoxin, Type A
The subject is to be injected intra-muscularly into a total of five sites: the mid-line of the procures muscle, the inferomedial aspect of each corrugator muscle and the superior middle aspect of each corrugator, at least 1 cm above the bony orbital rim. Each site is injected with 0.1 ml (4U), for a total of 20 U and 0.5 ml.
ATS Clinical Research, Santa Monica
Lead Sponsor
Evolus, Inc.
INDUSTRY